
SelectQuote, Inc. (NYSE:SLQT) (the &#34;Company&#34;) announced today that the Company received a notice (the &#34;Notice&#34;) from the New York Stock Exchange (the &#34;NYSE&#34;) indicating that the Company is no longer in compliance with

<p xmlns="http://www.w3.org/1999/xhtml">
SelectQuote, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SLQT">SLQT</a>) (the "Company") announced today that the Company received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company recently reported strong <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.selectquote.com%2Fnews%2Fnews-details%2F2026%2FSelectQuote-Inc--Reports-Second-Quarter-of-Fiscal-Year-2026-Results%2Fdefault.aspx&amp;esheet=54464574&amp;newsitemid=20260325352921&amp;lan=en-US&amp;anchor=fiscal+second+quarter+2026+results&amp;index=1&amp;md5=39f00519f50451f6a1d20c705641540e" shape="rect">fiscal second quarter 2026 results</a> on February 5<sup xmlns="http://www.w3.org/1999/xhtml">th</sup>. Earlier this year, the Company executed a new <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.selectquote.com%2Fnews%2Fnews-details%2F2026%2FSelectQuote-Secures-New-415-Million-Credit-Facility-Comprised-of-325-Million-Term-Loan-with-Pathlight-Capital-Alongside-90-Million-Revolving-Credit-Facility-with-UMB-Bank%2Fdefault.aspx&amp;esheet=54464574&amp;newsitemid=20260325352921&amp;lan=en-US&amp;anchor=%24415+million+credit+facility&amp;index=2&amp;md5=1b7722bcf38ff80f3ee43365ff7c7c8a" shape="rect">$415 million credit facility</a> which extends the majority of its debt maturities to 2031. SelectQuote's strong liquidity position and robust operating cash flow outlook provide the Company operational flexibility to execute its strategy and achieve its goals. The Company projects fiscal 2026 operating cash flow in the range of $25 million to $35 million and expects the business will continue to generate meaningful cash flow growth in years to come.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company has notified the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company intends to closely monitor its stock price during the cure period for non-compliance. The Company plans to take appropriate actions if necessary to maintain its listing on the NYSE. SelectQuote's common stock will continue to be listed and traded on the NYSE during the applicable cure period, subject to the Company's compliance with other NYSE continued listing standards.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Forward Looking Statements

</p><p xmlns="http://www.w3.org/1999/xhtml">
This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management's beliefs, and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control, including our ability to regain compliance with the continued listing standards of the NYSE within the applicable cure period and our ability to continue to comply with applicable NYSE listing standards. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, changes in reimbursement rates under our contracts with pharmacy benefit managers, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled "Risk Factors" in the most recent Annual Report on Form 10-K (the "Annual Report") and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

</p><p xmlns="http://www.w3.org/1999/xhtml">
About SelectQuote

</p><p xmlns="http://www.w3.org/1999/xhtml">
Founded in 1985, SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SLQT">SLQT</a>) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.

</p><p xmlns="http://www.w3.org/1999/xhtml">
With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home&#x2122; (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select, which proactively connects consumers with a wide breadth of healthcare services supporting their needs.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260325352921r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260325352921/en/" rel="nofollow">https://www.businesswire.com/news/home/20260325352921/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Investor Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Sloan Bohlen
<br xmlns="http://www.w3.org/1999/xhtml"></br>877-678-4083
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:investorrelations@selectquote.com" shape="rect">investorrelations@selectquote.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Media:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Matt Gunter
<br xmlns="http://www.w3.org/1999/xhtml"></br>913-286-4931
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:matt.gunter@selectquote.com" shape="rect">matt.gunter@selectquote.com</a>

</p>

SLQT

SelectQuote, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE; Plans to Take Appropriate Actions to Cure

SelectQuote Receives NYSE Non-Compliance Notice, Plans to Regain Compliance

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>SelectQuote, Inc. (NYSE:SLQT) (the &amp;#34;Company&amp;#34;) announced today that the Company received a notice (the &amp;#34;Notice&amp;#34;) from the New York Stock Exchange (the &amp;#34;NYSE&amp;#34;) indicating that the Company is no longer in compliance with</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>SelectQuote, Inc. has received a notice from the NYSE for failing to maintain a stock price above $1.00. The company is confident in its ability to regain compliance within six months and continues to report strong operating cash flows, which could provide stability during this period.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>SLQT received notice of non-compliance with NYSE pricing rules.</li><li>Stock averaged below $1.00 for 30 trading days.</li><li>Company aims to regain compliance within a six-month period.</li><li>Recent fiscal results indicate strong operating cash flow outlook.</li><li>SLQT has a $415 million credit facility supporting its operations.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Pathlight Capital (N/A)</strong>: Partnered in securing the $415 million credit facility.</li><li><strong>UMB Bank (N/A)</strong>: Also involved in providing credit facility.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This news falls under &#039;Corporate Developments&#039; as it highlights compliance issues with stock listing requirements and financial health. The company&#039;s proactive approach to addressing compliance is crucial for maintaining investor confidence in its operations.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Failure to regain compliance could lead to delisting risks.</li><li>Continued strong cash flow may stabilize investor confidence.</li><li>Any updates on compliance efforts could significantly affect share price.</li><li>The $415 million credit facility extends debt maturities, reducing near-term financial pressure.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>SLQT stock averaged below $1.00 for 30 trading days.</li><li>$415 million credit facility extends debt maturity to 2031.</li><li>Company projects $25 million to $35 million operating cash flow in fiscal 2026.</li><li>Non-compliance notice received on February 5, 2026.</li><li>Company has a six-month period to regain compliance.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>SLQT is a potential buy on recovery prospects as it aims to regain NYSE compliance.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
SelectQuote, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SLQT">SLQT</a>) (the "Company") announced today that the Company received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company recently reported strong <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.selectquote.com%2Fnews%2Fnews-details%2F2026%2FSelectQuote-Inc--Reports-Second-Quarter-of-Fiscal-Year-2026-Results%2Fdefault.aspx&amp;esheet=54464574&amp;newsitemid=20260325352921&amp;lan=en-US&amp;anchor=fiscal+second+quarter+2026+results&amp;index=1&amp;md5=39f00519f50451f6a1d20c705641540e" shape="rect">fiscal second quarter 2026 results</a> on February 5<sup xmlns="http://www.w3.org/1999/xhtml">th</sup>. Earlier this year, the Company executed a new <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.selectquote.com%2Fnews%2Fnews-details%2F2026%2FSelectQuote-Secures-New-415-Million-Credit-Facility-Comprised-of-325-Million-Term-Loan-with-Pathlight-Capital-Alongside-90-Million-Revolving-Credit-Facility-with-UMB-Bank%2Fdefault.aspx&amp;esheet=54464574&amp;newsitemid=20260325352921&amp;lan=en-US&amp;anchor=%24415+million+credit+facility&amp;index=2&amp;md5=1b7722bcf38ff80f3ee43365ff7c7c8a" shape="rect">$415 million credit facility</a> which extends the majority of its debt maturities to 2031. SelectQuote's strong liquidity position and robust operating cash flow outlook provide the Company operational flexibility to execute its strategy and achieve its goals. The Company projects fiscal 2026 operating cash flow in the range of $25 million to $35 million and expects the business will continue to generate meaningful cash flow growth in years to come.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company has notified the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice if, on the last trading day of any calendar month during the cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The Company intends to closely monitor its stock price during the cure period for non-compliance. The Company plans to take appropriate actions if necessary to maintain its listing on the NYSE. SelectQuote's common stock will continue to be listed and traded on the NYSE during the applicable cure period, subject to the Company's compliance with other NYSE continued listing standards.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Forward Looking Statements

</p><p xmlns="http://www.w3.org/1999/xhtml">
This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management's beliefs, and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control, including our ability to regain compliance with the continued listing standards of the NYSE within the applicable cure period and our ability to continue to comply with applicable NYSE listing standards. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, changes in reimbursement rates under our contracts with pharmacy benefit managers, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled "Risk Factors" in the most recent Annual Report on Form 10-K (the "Annual Report") and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

</p><p xmlns="http://www.w3.org/1999/xhtml">
About SelectQuote

</p><p xmlns="http://www.w3.org/1999/xhtml">
Founded in 1985, SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SLQT">SLQT</a>) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.

</p><p xmlns="http://www.w3.org/1999/xhtml">
With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home&#x2122; (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select, which proactively connects consumers with a wide breadth of healthcare services supporting their needs.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260325352921r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260325352921/en/" rel="nofollow">https://www.businesswire.com/news/home/20260325352921/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Investor Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Sloan Bohlen
<br xmlns="http://www.w3.org/1999/xhtml"></br>877-678-4083
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:investorrelations@selectquote.com" shape="rect">investorrelations@selectquote.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Media:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Matt Gunter
<br xmlns="http://www.w3.org/1999/xhtml"></br>913-286-4931
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:matt.gunter@selectquote.com" shape="rect">matt.gunter@selectquote.com</a>

</p>

SelectQuote, Inc. has received a notice from the NYSE for failing to maintain a stock price above $1.00. The company is confident in its ability to regain compliance within six months and continues to report strong operating cash flows, which could provide stability during this period.

SelectQuote, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE; Plans to Take Appropriate Actions to Cure

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News